Truncation of blood curves to enhance imaging and therapy with monoclonal antibodies.
Truncation of blood curves to enhance imaging and therapy with monoclonal antibodies.
复制标题
截断血液曲线以增强单克隆抗体的成像和治疗。
DOI:
10.1118/1.598963
复制
发表时间:
2000
期刊:
影响因子:
3.8
通讯作者:
Wong,JY
中科院分区:
文献类型:
--
作者:
Williams,LE;Liu,A;Wu,AM;Yazaki,PJ;Yamauchi,DM;Lopatin,G;Raubitschek,AA;Wong,JY
Targeting of monoclonal antibody (Mab) to solid tumor sites is a function of the blood curve of activity versus time. It has been suggested that the blood curve be artificially reduced to approach zero so that the contrast between tumor and blood uptake is maximized. We analyzed tumor uptake as a function of the time of blood curve truncation. By using a convolution approach, we were able to find the optimal times for setting the blood curve to zero in either diagnostic or therapeutic animal examples. Two iodinated anti‐CEA engineered fragments, diabody and minibody, were considered using previous data from nude mouse studies involving the LS174T colorectal tumor model. Figures of merit (FOMs) were used to compare ordinary and truncated blood curves and their associated tumor accumulations. Using a label, it was seen that the appropriate time for diagnostic truncation occurred when tumor uptake, as measured, was a maximum. The corresponding point for therapy (with as a label) was at infinite time. We also demonstrated that the use of traditional indices led to ambiguities in the choice of truncation times. The traditional therapy index, the ratio of the integral of the tumor uptake to the integral of the blood uptake, was found to be a numerical constant independent of This ratio was proved to be the integral of the tumor impulse response function. Use of such convolution techniques to assess truncation of the perfused material is probably also applicable to multistep processes as well as to lesion targeting with other tumor‐specific pharmaceuticals.